UBS has reiterated a buy rating on Colgate-Palmolive Indiasetting a target price of ₹3,000 per shareas it views current cyclical weakness as a buying opportunity with strong long-term structural positioning.

The brokerage noted that Q4 performance remained soft and the near-term outlook is still tepidbut emphasized that Colgate is structurally well-placed to deliver high single-digit growth going forward. UBS believes the company’s strategic positioning has strengthenedsupported by its strong brand, product pipeline, and distribution.

Valuation-wise, Colgate trades at 39x FY27 estimated earningswhich UBS said reflects near-term softness but does not fully capture the potential upside over a one-year horizon.